The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
The U.S. stock market had one of its worst weeks so far in 2025, weighed down by inflation concerns and weaker-than-expected ...
14h
State of New Jersey Common Pension Fund D decreased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free ...
Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...
Axios Vitals on MSN23h
Ozempic and Wegovy shortage ends, setting up weight loss drug showdownOzempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback